Oral Shigella Vaccine Shows 89% Efficacy In Human Challenge Trial
Aug 07
1
An oral Shigella vaccine developed at the Walter Reed Army Institute of Research showed 89% efficacy in a human challenge trial, offering a potential new tool against deadly diarrheal disease. NPR
